Repaglinide
Written By Dr. MayankLast updated 25 Nov 2025 | 09:34 AM (UTC)
Repaglinide Uses
Repaglinide is used in the treatment of type 2 diabetes mellitus.
How Repaglinide works
Repaglinide is an anti-diabetic medication. It increases the amount of insulin released by the pancreas which prevents blood glucose from rising very high after meals.
Common side effects of Repaglinide
Upper respiratory tract infection, Hypoglycemia (low blood glucose level), Headache
Want to Know More
Read Our Editorial PolicyMedicine brands for Repaglinide
Novonorm
Novo Nordisk India Pvt Ltd
₹272 to ₹680
4 variant(s)
Repawick
Elder Pharmaceuticals Ltd
₹182 to ₹245
2 variant(s)
Repalite
Merdica Private Limited
₹51 to ₹138
3 variant(s)
Qrepa
Q Check Pharmaceuticals Private Limited
₹99 to ₹130
2 variant(s)
Repanza
Mcronus Lifescience Pvt Ltd
₹60 to ₹157
3 variant(s)
Repomine
Shinto Organics (P) Limited
₹96 to ₹132
2 variant(s)
Ripadep
Globus Labs
₹70 to ₹135
3 variant(s)
Q Repa
Q Check Speciality Care
₹40 to ₹144
3 variant(s)
Repa X
AAR ESS Remedies Pvt Ltd
₹89 to ₹158
3 variant(s)
Reglide
Grownbury Pharmaceuticals Pvt Ltd
₹58 to ₹89
2 variant(s)
Expert advice for Repaglinide
- For best results, take Repaglinide 15 to 30 minutes before a meal.
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Repaglinide
- It may cause dizziness. Do not drive or do anything that requires mental focus until you know how Repaglinide affects you.
- It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety.
- Monitor your blood sugar levels regularly while you are taking this medicine.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
- Repaglinide results in fast and effective control of high blood sugar following meals.
- For best results, take Repaglinide 15 to 30 minutes before a meal.
- If you miss a meal, skip your dose to avoid hypoglycemia (low blood sugar level).
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Repaglinide
- It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety.
- Monitor your blood sugar levels regularly while you are taking this medicine.
- It may cause dizziness. Do not drive or do anything that requires mental focus until you know how Repaglinide affects you.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
Frequently asked questions for Repaglinide
Repaglinide starts working 30 minutes after it has been taken. After you take Repaglinide, the insulin levels increase causing a decrease in the blood sugar levels. The effect usually lasts for 4 hours.
No, you should avoid alcohol while taking Repaglinide since alcohol interferes with the working of Repaglinide. You may experience signs and symptoms of low blood sugar levels which include weakness, shakiness, cold sweat, cool pale skin, rapid heartbeat, tremors, extreme hunger, dizziness, headache and anxiety.
Yes, it can be taken with other antidiabetic drugs but according to your doctor’s advice. But since all these drugs lower blood sugar levels, regular monitoring of blood sugar levels is recommended.
No, you should not breastfeed your baby because if Repaglinide passes in breast milk, your baby may experience low blood sugar levels which is harmful for your baby. Ask your doctor for advice.
You should inform your doctor and take his advice. If you cannot avoid using clopidogrel with Repaglinide, take 0.5 mg Repaglinide before each meal. The total daily dose should not be more than 4 mg. Monitor your blood sugar levels more frequently.



